u/tb500_tangent
Thymosin fragment naming is a mess and the mess hides quality problems.
member · joined 14 Mar 2024
Comments — page 2 of 4
comment on Spain: 503B, and what it actually costs here in c/compounding · 4 points · 2 months ago
Not convinced.
Yes, exactly this, and it is the bit that took me 14 weeks to accept.
comment on [Question] how do you actually verify TB-500 in c/researchpeptides · 62 points · 2 months ago
Removed a chain here. The rule is one line long and it is not negotiable.
comment on SELECT: the version I wish someone had shown me in week 1 in c/trialwatch · 25 points · 2 months ago
off-label use data is different from approved-indication data
comment on [Discussion] can we stop arguing about research peptides until somebody posts a number in c/researchpeptides · 11 points · 2 months ago
comment on TB-500 — 11 things I got wrong before I got it right in c/researchpeptides · 12 points · 2 months ago
evidence-level statements required: in vitro, rodent, or human
comment on endpoint — my 2-week log, condensed into one table in c/trialwatch · 1 points · 3 months ago
phase 2 is not phase 3, smaller n and shorter trial
Disagree on that part. 93.7% and 99.3% on the same vial is normal.
comment on telehealth: the version I wish someone had shown me in week 1 in c/compounding · -25 points · 3 months ago
Strongly agree. API source transparency matters.
comment on someone explain identity to me like I have not read a paper in years in c/researchpeptides · -32 points · 3 months ago
[removed by moderator]
Yes, exactly this, and it is the bit that took me 38 weeks to accept.
comment on [Question] import — what am I missing here in c/customs · 40 points · 4 months ago
Mechanistically the bit that matters is import. It explains most of the early profile and a decent chunk of the outcome.
comment on anyone else notice research peptides kicking in around week 14 in c/researchpeptides · 157 points · 4 months ago
Tracking number removed. It identifies both ends of a shipment.
comment on why does nobody talk about API source in c/compounding · 127 points · 4 months ago
Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.
comment on what would you tell week-1 you about secretagogue in c/researchpeptides · 1 points · 5 months ago
name the compound precisely, TB-500 and Thymosin Beta-4 are not the same
comment on what would you tell week-1 you about secretagogue in c/researchpeptides · 33 points · 5 months ago
Tracking number removed. It identifies both ends of a shipment.
comment on someone explain research peptides to me like I have not read a paper in years in c/researchpeptides · 73 points · 5 months ago
This is an urgent-care question wearing a forum question's clothes. Please contact a clinician rather than waiting for replies.
comment on [Results] 46 weeks on 7.5mg, full numbers, ask me anything boring in c/bpc157 · 1 points · 5 months ago
Maintenance for 5 months now. Weight moves within about 3kg and the dose is a quarter of what it peaked at.
comment on [Question] TB-500 — what am I missing here in c/researchpeptides · 10 points · 6 months ago
Removed a chain here. The rule is one line long and it is not negotiable.
comment on genuine question about hazard ratio that I am slightly embarrassed to ask in c/trialwatch · 0 points · 6 months ago
No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.
comment on what would you tell week-1 you about handling in c/researchpeptides · 188 points · 7 months ago
Tracking number removed. It identifies both ends of a shipment.
comment on rodent data: what the trials say vs what this community says in c/bpc157 · 223 points · 8 months ago
Strongly agree. Zero human controlled data.
comment on am I the only one who found TB-500 harder than the injections in c/researchpeptides · 36 points · 8 months ago
supply-chain naming is a mess, ask for HPLC